On Thursday 23 October we were delighted to welcome eight companies onto the second year of our West of England Commercialisation Academy, designed to support health and care innovators whose products and services offer potential for wider adoption and scale.
Run in partnership with Triple Chasm, the eight-week programme will help each of the companies to develop their strategic commercialisation plans. The programme is based on the Triple Chasm Model®, which provides a holistic data-driven framework built on research into around 3,000 products taken to market.
The eight successful companies selected for our second Commercialisation Academy are:
- Sommus Scientific Limited – realtime blood propofol concentration monitoring
- Virtually Health Systems Ltd – online GP practice
- NuvoAir – remote monitoring for conditions such as asthma and COPD
- Pal – digital care app for families affected by serious illnesses
- Tend VR – providing mindfulness based cognitive therapy via virtual reality (VR)
- Deontics Limited – clinically driven artificial intelligence (AI) platform providing treatment recommendations
- SuperPenguin – app to support speech and language therapy
- Lingly – evidence-based language learning based on context and conversation
Learn more about some of the participating companies and their innovations in this short video.
Alex Leach, Deputy Director of Programmes at Health Innovation West of England, said: “We are delighted to welcome these companies and start the second year of our successful Commercialisation Academy. Innovators that attended our first year have gone on to achieve many successes, including: winning grants and investments; securing NHS contacts; achieving a place on the NHS Innovation Accelerator programme; winning a prestigious national award; and forming strategic partnerships. Over this eight-week programme we are excited to learn more about this year’s cohort and see how we can help them achieve their goals.”
The free eight-week course, designed to help innovators develop strategic commercialisation plans, is based on the Triple Chasm Model®, a data-driven framework developed from research into commercialisation journeys. It provides expert mentoring, networking opportunities, and bespoke training to help innovators navigate the challenges of scaling their innovations within the NHS.
Sam Dods, Chief Operating Officer and co-founder of Triple Chasm, said: “We are delighted to be working with Health Innovation West of England for the second year running. The programme has proven benefits in supporting later-stage health and care innovators to navigate the most challenging stage of the commercialisation journey, from successful prototyping and early customer traction to development of a scalable business model. The West of England Commercialisation Academy offers vital skills, insights and support for innovators looking to gain traction, adoption and spread in the NHS.”
Sign up to our Innovation Exchange newsletter for news on the Commercialisation Academy.
Posted on November 3, 2025
